B. Zeng

发表

Pathology of GM2 Gangliosidosis in Jacob Sheep

J. Alroy, B. Porter, E. Kolodny, 2011, Veterinary pathology.

Krabbe disease: clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards.

J. Abdenur, J. Orsini, M. Caggana, 2012, Molecular genetics and metabolism.

Globoid cell leukodystrophy (Krabbe disease): Normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations

W. Krivit, G. Pastores, S. Raghavan, 2005, Journal of Inherited Metabolic Disease.

In Vivo and In Vitro Glioma Cell Killing Induced by An Adenovirus Expressing Both Cytosine Deaminase and Thymidine Kinase and Its Association with Interferon-α

D. Zagzag, E. Kolodny, B. Zeng, 1999 .

Rapid detection of three large novel deletions of the aspartoacylase gene in non-Jewish patients with Canavan disease.

P. Leone, G. Pastores, S. Raghavan, 2006, Molecular genetics and metabolism.

Mutation analysis of the aspartoacylase gene in non-Jewish patients with Canavan disease.

P. Leone, G. Pastores, S. Raghavan, 2006, Advances in experimental medicine and biology.

Isolation and characterization of the normal canine β-galactosidase gene and its mutation in a dog model of GM1-gangliosidosis

G. Johnson, J. Alroy, G. Pastores, 2000, Journal of Inherited Metabolic Disease.

GM2 gangliosidosis in British Jacob sheep.

M. Jackson, E. Kolodny, M. Jeffrey, 2014, Journal of comparative pathology.

GM1-gangliosidosis in American black bears: clinical, pathological, biochemical and molecular genetic characterization.

J. Alroy, T. Seyfried, S. Muthupalani, 2014, Molecular genetics and metabolism.

Tay-Sachs disease in Jacob sheep.

J. Alroy, B. Porter, E. Kolodny, 2010, Molecular genetics and metabolism.

Gaucher disease: the N370S mutation in Ashkenazi Jewish and Spanish patients has a common origin and arose several thousand years ago.

B. Cormand, D. Grinberg, A. Chabás, 1999, American journal of human genetics.

Correlation of glioma cell regression with inhibition of insulin-like growth factor 1 and insulin-like growth factor-binding protein-2 expression.

M. A. Gama Sosa, E. Kolodny, B. Zeng, 1997, Neuroendocrinology.

Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson’s disease

T. Wisniewski, W. Shan, G. Pastores, 2002, Neuroscience.

Animal models for lysosomal storage disorders

G. Pastores, B. Zeng, P. Torres, 2013, Biochemistry (Moscow).

Multiple sulfatase deficiency: clinical report and description of two novel mutations in a Brazilian patient

G. Pastores, I. Schwartz, M. Burin, 2009, Metabolic Brain Disease.

Association Between Progranulin and Gaucher Disease

Ying Sun, Guilin Wang, R. Saunders-Pullman, 2016, EBioMedicine.

Late-onset Tay-Sachs disease: Phenotypic characterization and genotypic correlations in 21 affected patients

C. Zaroff, J. Gianutsos, G. Pastores, 2005, Genetics in Medicine.

On the age of the most prevalent Gaucher disease-causing mutation, N370S.

B. Cormand, D. Grinberg, A. Chabás, 2000, American journal of human genetics.

Mild‐onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene

D. Shera, Andrew Freese, L. Bilaniuk, 2006, Annals of neurology.

Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease

R. De Gasperi, R. Gasperi, P. Leone, 2002, Journal of Inherited Metabolic Disease.

Spontaneous appearance of Tay-Sachs disease in an animal model.

J. Alroy, G. Pastores, S. Raghavan, 2008, Molecular genetics and metabolism.

Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV.

G. Pastores, E. Kolodny, B. Zeng, 2001, Genetic Testing.